State of Wyoming’s Syndax Pharmaceuticals SNDX Stock Holding History

State of Wyoming’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.43K	Buy	+340	New	+$7.07K	﹤0.01%	1839
2023 Q2	–	Sell	-3,242	Closed	-$68.5K	–	1761
2023 Q1	$68.5K	Buy	+3,242	New	+$80.6K	0.02%	969
2022 Q4	–	Sell	-1,234	Closed	-$30K	–	1750
2022 Q3	$30K	Buy	1,234 +102	+9%	+$2.29K	0.01%	1185
2022 Q2	$22K	Sell	1,132 -4,801	-81%	-$80K	0.01%	1392
2022 Q1	$103K	Buy	5,933 +4,181	+239%	+$70.4K	0.05%	569
2021 Q4	$38K	Buy	1,752 +172	+11%	+$3.18K	0.02%	1232
2021 Q3	$30K	Buy	1,580 +871	+123%	+$14.5K	0.02%	880
2021 Q2	$12K	Buy	+709	New	+$13K	0.01%	996

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

State of Wyoming's SNDX Position: Q2 2026 in Review

State of Wyoming opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 340 shares worth $7.43K. The stake represents ﹤0.01% of the portfolio and ranks #1839 among its holdings. This is a return to the name: State of Wyoming previously reported a position in SNDX as recently as Q1 2023.

State of Wyoming first reported a position in SNDX in Q2 2021 and has held it in 8 quarters since. The position peaked at $103K in Q1 2022. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

State of Wyoming held 340 shares of Syndax Pharmaceuticals worth $7.43K as of Q2 2026.
Syndax Pharmaceuticals was a new State of Wyoming position in Q2 2026.
Syndax Pharmaceuticals made up ﹤0.01% of State of Wyoming's portfolio in Q2 2026, its #1839 holding.
State of Wyoming first reported a position in Syndax Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
State of Wyoming's Syndax Pharmaceuticals position peaked at $103K in Q1 2022.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.